 Theodore Randolph
Concepts (523)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Monoclonal | 35 | 2025 | 1428 | 6.530 |
Why?
| | Protein Aggregates | 25 | 2022 | 72 | 5.380 |
Why?
| | Freeze Drying | 44 | 2024 | 82 | 4.840 |
Why?
| | Silicone Oils | 15 | 2017 | 28 | 4.480 |
Why?
| | Recombinant Proteins | 54 | 2019 | 1357 | 4.280 |
Why?
| | Proteins | 32 | 2022 | 1012 | 4.030 |
Why?
| | Particle Size | 41 | 2025 | 394 | 4.030 |
Why?
| | Chemistry, Pharmaceutical | 36 | 2021 | 108 | 4.010 |
Why?
| | Drug Stability | 52 | 2025 | 167 | 3.620 |
Why?
| | Immunoglobulin G | 25 | 2025 | 886 | 3.240 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 14 | 2019 | 253 | 2.990 |
Why?
| | Polysorbates | 24 | 2025 | 41 | 2.960 |
Why?
| | Antibody Formation | 13 | 2017 | 299 | 2.900 |
Why?
| | Excipients | 29 | 2025 | 54 | 2.780 |
Why?
| | Ebolavirus | 4 | 2022 | 35 | 2.760 |
Why?
| | Microscopy | 7 | 2025 | 144 | 2.680 |
Why?
| | Drug Compounding | 19 | 2024 | 98 | 2.660 |
Why?
| | Machine Learning | 7 | 2025 | 496 | 2.650 |
Why?
| | Immunoglobulins, Intravenous | 9 | 2021 | 132 | 2.520 |
Why?
| | Human Growth Hormone | 10 | 2014 | 46 | 2.450 |
Why?
| | Surface-Active Agents | 19 | 2020 | 92 | 2.430 |
Why?
| | Vaccines | 5 | 2024 | 411 | 2.270 |
Why?
| | Muramidase | 13 | 2022 | 77 | 2.240 |
Why?
| | Adjuvants, Immunologic | 11 | 2024 | 226 | 2.140 |
Why?
| | Aluminum Hydroxide | 8 | 2019 | 12 | 2.050 |
Why?
| | Protein Folding | 34 | 2012 | 282 | 2.020 |
Why?
| | Water | 24 | 2022 | 464 | 2.010 |
Why?
| | Hemorrhagic Fever, Ebola | 3 | 2021 | 36 | 1.990 |
Why?
| | Growth Hormone | 6 | 2016 | 101 | 1.870 |
Why?
| | Adsorption | 23 | 2025 | 147 | 1.860 |
Why?
| | Nanoparticles | 10 | 2020 | 484 | 1.750 |
Why?
| | Image Processing, Computer-Assisted | 6 | 2025 | 784 | 1.730 |
Why?
| | Protein Conformation | 42 | 2017 | 930 | 1.710 |
Why?
| | Papillomavirus Vaccines | 3 | 2023 | 243 | 1.590 |
Why?
| | Protein Stability | 29 | 2020 | 178 | 1.550 |
Why?
| | Syringes | 8 | 2019 | 43 | 1.530 |
Why?
| | Viral Vaccines | 3 | 2022 | 98 | 1.480 |
Why?
| | Temperature | 28 | 2025 | 680 | 1.450 |
Why?
| | Antibodies | 4 | 2021 | 414 | 1.390 |
Why?
| | Unsupervised Machine Learning | 3 | 2025 | 22 | 1.380 |
Why?
| | Drug Packaging | 6 | 2020 | 41 | 1.330 |
Why?
| | Mice, Inbred BALB C | 15 | 2025 | 1271 | 1.310 |
Why?
| | Technology, Pharmaceutical | 7 | 2015 | 21 | 1.310 |
Why?
| | Stress, Mechanical | 10 | 2023 | 475 | 1.220 |
Why?
| | Sucrose | 20 | 2019 | 109 | 1.220 |
Why?
| | Glass | 7 | 2019 | 43 | 1.200 |
Why?
| | Thermodynamics | 27 | 2009 | 421 | 1.170 |
Why?
| | Aluminum | 2 | 2024 | 42 | 1.160 |
Why?
| | Immunoconjugates | 5 | 2019 | 116 | 1.150 |
Why?
| | Microspheres | 6 | 2016 | 137 | 1.150 |
Why?
| | Papillomavirus Infections | 2 | 2023 | 331 | 1.150 |
Why?
| | Trehalose | 11 | 2022 | 32 | 1.100 |
Why?
| | Freezing | 17 | 2019 | 91 | 1.070 |
Why?
| | Adjuvants, Pharmaceutic | 4 | 2022 | 11 | 1.070 |
Why?
| | Emulsions | 6 | 2022 | 54 | 1.040 |
Why?
| | Complement Activation | 2 | 2019 | 412 | 1.000 |
Why?
| | Solubility | 19 | 2019 | 249 | 0.980 |
Why?
| | Rabies Vaccines | 1 | 2025 | 3 | 0.980 |
Why?
| | Rabies | 1 | 2025 | 4 | 0.970 |
Why?
| | Delayed-Action Preparations | 5 | 2024 | 180 | 0.950 |
Why?
| | Lipase | 2 | 2025 | 68 | 0.930 |
Why?
| | Serum Albumin | 5 | 2015 | 150 | 0.920 |
Why?
| | Glycoproteins | 3 | 2022 | 345 | 0.910 |
Why?
| | Amyloid | 6 | 2021 | 89 | 0.910 |
Why?
| | Virion | 2 | 2023 | 90 | 0.850 |
Why?
| | Chromatography, Gel | 15 | 2016 | 127 | 0.840 |
Why?
| | Drug Contamination | 7 | 2019 | 52 | 0.820 |
Why?
| | Immunologic Factors | 2 | 2019 | 239 | 0.820 |
Why?
| | Capsid | 1 | 2023 | 93 | 0.820 |
Why?
| | Colloids | 7 | 2018 | 60 | 0.820 |
Why?
| | Mice | 27 | 2025 | 17843 | 0.810 |
Why?
| | Protein Interaction Mapping | 2 | 2016 | 109 | 0.810 |
Why?
| | Bacteriophages | 1 | 2024 | 95 | 0.800 |
Why?
| | Root Cause Analysis | 1 | 2022 | 8 | 0.800 |
Why?
| | Inclusion Bodies | 4 | 2010 | 25 | 0.770 |
Why?
| | Surface Properties | 19 | 2019 | 414 | 0.770 |
Why?
| | Interferon-gamma | 6 | 2003 | 790 | 0.740 |
Why?
| | Aluminum Oxide | 3 | 2025 | 13 | 0.740 |
Why?
| | Animals | 46 | 2025 | 37011 | 0.740 |
Why?
| | Immunotherapy, Adoptive | 1 | 2025 | 324 | 0.730 |
Why?
| | Protein Structure, Secondary | 20 | 2014 | 373 | 0.730 |
Why?
| | Hydrogen-Ion Concentration | 19 | 2013 | 566 | 0.720 |
Why?
| | Capsid Proteins | 3 | 2021 | 94 | 0.720 |
Why?
| | Alphapapillomavirus | 1 | 2021 | 39 | 0.720 |
Why?
| | Bacteriophage lambda | 1 | 2022 | 88 | 0.720 |
Why?
| | Antibodies, Viral | 5 | 2025 | 623 | 0.690 |
Why?
| | Marburgvirus | 1 | 2020 | 10 | 0.690 |
Why?
| | Cell Survival | 1 | 2024 | 1122 | 0.690 |
Why?
| | Granulocyte Colony-Stimulating Factor | 4 | 2012 | 74 | 0.690 |
Why?
| | Recombinant Fusion Proteins | 5 | 2012 | 665 | 0.690 |
Why?
| | Spectrometry, Fluorescence | 10 | 2021 | 172 | 0.680 |
Why?
| | Biotechnology | 3 | 2010 | 43 | 0.680 |
Why?
| | Hydrostatic Pressure | 8 | 2011 | 18 | 0.670 |
Why?
| | Benzyl Alcohol | 6 | 2011 | 12 | 0.670 |
Why?
| | Fluorescent Dyes | 3 | 2018 | 327 | 0.660 |
Why?
| | Gels | 3 | 2016 | 82 | 0.650 |
Why?
| | Protein Denaturation | 16 | 2015 | 74 | 0.640 |
Why?
| | Polyvinyl Chloride | 1 | 2019 | 10 | 0.630 |
Why?
| | Drug Storage | 14 | 2021 | 58 | 0.630 |
Why?
| | Diethylhexyl Phthalate | 1 | 2019 | 15 | 0.630 |
Why?
| | Sialoglycoproteins | 5 | 2006 | 159 | 0.630 |
Why?
| | Ebola Vaccines | 1 | 2019 | 4 | 0.620 |
Why?
| | Benzothiazoles | 2 | 2018 | 33 | 0.590 |
Why?
| | Antigens | 4 | 2024 | 358 | 0.580 |
Why?
| | Osmolar Concentration | 9 | 2016 | 174 | 0.580 |
Why?
| | T-Lymphocytes | 2 | 2025 | 1999 | 0.580 |
Why?
| | Spectrophotometry, Infrared | 14 | 2014 | 54 | 0.570 |
Why?
| | Buffers | 12 | 2014 | 56 | 0.560 |
Why?
| | Insulin | 3 | 2021 | 2398 | 0.560 |
Why?
| | Hemoglobins | 6 | 1999 | 356 | 0.560 |
Why?
| | Guanidine | 12 | 2014 | 21 | 0.560 |
Why?
| | Circular Dichroism | 17 | 2014 | 151 | 0.550 |
Why?
| | Humans | 83 | 2025 | 137514 | 0.550 |
Why?
| | Antibodies, Neutralizing | 4 | 2025 | 282 | 0.540 |
Why?
| | Kinetics | 19 | 2010 | 1679 | 0.540 |
Why?
| | Protein Structure, Tertiary | 15 | 2015 | 869 | 0.540 |
Why?
| | Scattering, Radiation | 10 | 2012 | 101 | 0.530 |
Why?
| | Solutions | 15 | 2015 | 170 | 0.530 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 151 | 0.520 |
Why?
| | Calorimetry, Differential Scanning | 9 | 2015 | 38 | 0.520 |
Why?
| | Polyesters | 6 | 2004 | 77 | 0.510 |
Why?
| | Complement System Proteins | 1 | 2019 | 328 | 0.510 |
Why?
| | Rheology | 6 | 2019 | 91 | 0.490 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 252 | 0.490 |
Why?
| | Powders | 5 | 2022 | 43 | 0.490 |
Why?
| | Oncogene Proteins, Viral | 1 | 2015 | 23 | 0.480 |
Why?
| | Models, Chemical | 6 | 2012 | 268 | 0.470 |
Why?
| | Anthrax Vaccines | 1 | 2015 | 7 | 0.470 |
Why?
| | Ovalbumin | 1 | 2015 | 183 | 0.470 |
Why?
| | Chromatography, High Pressure Liquid | 10 | 2016 | 595 | 0.470 |
Why?
| | Escherichia coli | 4 | 2022 | 815 | 0.470 |
Why?
| | Crystallization | 8 | 2019 | 144 | 0.460 |
Why?
| | Lipid A | 1 | 2015 | 29 | 0.460 |
Why?
| | Serum Albumin, Bovine | 3 | 2015 | 64 | 0.450 |
Why?
| | Databases, Factual | 2 | 2017 | 1351 | 0.450 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 10 | 2011 | 86 | 0.450 |
Why?
| | Pressure | 10 | 2009 | 244 | 0.450 |
Why?
| | Polyethylene Glycols | 10 | 2014 | 640 | 0.440 |
Why?
| | Light | 10 | 2012 | 383 | 0.430 |
Why?
| | Flow Cytometry | 2 | 2024 | 1185 | 0.430 |
Why?
| | Pharmaceutical Preparations | 4 | 2018 | 179 | 0.420 |
Why?
| | Ricin | 1 | 2013 | 8 | 0.420 |
Why?
| | Preservatives, Pharmaceutical | 2 | 2011 | 26 | 0.410 |
Why?
| | Ultraviolet Rays | 3 | 2014 | 389 | 0.410 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 5 | 2015 | 346 | 0.410 |
Why?
| | Algorithms | 5 | 2024 | 1702 | 0.400 |
Why?
| | Stainless Steel | 2 | 2010 | 22 | 0.400 |
Why?
| | Streptavidin | 2 | 2009 | 14 | 0.400 |
Why?
| | Vaccines, Subunit | 1 | 2013 | 49 | 0.400 |
Why?
| | Polymers | 4 | 2004 | 495 | 0.400 |
Why?
| | Protein Binding | 17 | 2018 | 2229 | 0.400 |
Why?
| | Hydroxyethyl Starch Derivatives | 3 | 2009 | 9 | 0.400 |
Why?
| | Histidine | 2 | 2011 | 65 | 0.390 |
Why?
| | Vaccines, Synthetic | 3 | 2009 | 126 | 0.390 |
Why?
| | Drug Delivery Systems | 6 | 2011 | 363 | 0.380 |
Why?
| | Enzyme Stability | 5 | 2009 | 73 | 0.380 |
Why?
| | Chemical Precipitation | 8 | 2009 | 38 | 0.380 |
Why?
| | Urea | 8 | 2018 | 81 | 0.380 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2012 | 807 | 0.380 |
Why?
| | Deuterium Exchange Measurement | 2 | 2011 | 30 | 0.380 |
Why?
| | Chromatography, Affinity | 1 | 2011 | 88 | 0.370 |
Why?
| | Peptides | 1 | 2018 | 986 | 0.370 |
Why?
| | Mice, Inbred C57BL | 10 | 2017 | 5792 | 0.370 |
Why?
| | Transition Temperature | 5 | 2014 | 28 | 0.370 |
Why?
| | Static Electricity | 4 | 2020 | 120 | 0.350 |
Why?
| | Abatacept | 4 | 2012 | 53 | 0.350 |
Why?
| | Ribonuclease, Pancreatic | 2 | 2009 | 12 | 0.330 |
Why?
| | Lactic Acid | 4 | 2011 | 306 | 0.320 |
Why?
| | Methionine | 3 | 2012 | 159 | 0.320 |
Why?
| | Tungsten | 1 | 2009 | 30 | 0.320 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 5 | 2019 | 191 | 0.320 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2009 | 40 | 0.320 |
Why?
| | Microscopy, Electron, Transmission | 3 | 2021 | 153 | 0.320 |
Why?
| | Trastuzumab | 3 | 2019 | 101 | 0.320 |
Why?
| | Cellulase | 2 | 2006 | 32 | 0.300 |
Why?
| | Botulinum Toxins | 4 | 2010 | 43 | 0.300 |
Why?
| | Pharmaceutical Solutions | 6 | 2014 | 14 | 0.300 |
Why?
| | Viscosity | 4 | 2018 | 92 | 0.290 |
Why?
| | Albumins | 3 | 2013 | 114 | 0.290 |
Why?
| | Alkaline Phosphatase | 1 | 2009 | 148 | 0.290 |
Why?
| | Mass Spectrometry | 4 | 2010 | 741 | 0.290 |
Why?
| | DNA | 3 | 2023 | 1460 | 0.280 |
Why?
| | Carbon Dioxide | 2 | 2004 | 267 | 0.280 |
Why?
| | Interferon-alpha | 3 | 2013 | 198 | 0.280 |
Why?
| | Nanostructures | 3 | 2005 | 108 | 0.270 |
Why?
| | Microscopy, Electron, Scanning | 8 | 2005 | 202 | 0.270 |
Why?
| | Macrophages, Alveolar | 3 | 2006 | 392 | 0.270 |
Why?
| | Anilino Naphthalenesulfonates | 4 | 2018 | 10 | 0.270 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 891 | 0.270 |
Why?
| | Hot Temperature | 7 | 2018 | 409 | 0.260 |
Why?
| | Protein Unfolding | 4 | 2019 | 31 | 0.260 |
Why?
| | Oils | 2 | 2018 | 21 | 0.260 |
Why?
| | Chickens | 5 | 2017 | 192 | 0.260 |
Why?
| | Surface Tension | 2 | 2023 | 8 | 0.260 |
Why?
| | Filtration | 3 | 2014 | 73 | 0.260 |
Why?
| | Female | 16 | 2025 | 73162 | 0.250 |
Why?
| | Quality Control | 3 | 2024 | 171 | 0.250 |
Why?
| | Protein Biosynthesis | 1 | 2009 | 434 | 0.250 |
Why?
| | Griseofulvin | 1 | 2005 | 2 | 0.250 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 5 | 2010 | 144 | 0.250 |
Why?
| | Decanoic Acids | 1 | 2005 | 8 | 0.250 |
Why?
| | Anhydrides | 1 | 2005 | 18 | 0.250 |
Why?
| | Rabies virus | 1 | 2025 | 1 | 0.250 |
Why?
| | Disulfides | 2 | 2005 | 107 | 0.240 |
Why?
| | Dimerization | 8 | 2014 | 198 | 0.240 |
Why?
| | Immunogenetic Phenomena | 2 | 2016 | 7 | 0.240 |
Why?
| | Quartz Crystal Microbalance Techniques | 1 | 2025 | 4 | 0.240 |
Why?
| | Subtilisins | 2 | 2005 | 10 | 0.230 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2005 | 22 | 0.230 |
Why?
| | Injections, Intramuscular | 1 | 2025 | 128 | 0.230 |
Why?
| | Trypsin Inhibitor, Kunitz Soybean | 1 | 2004 | 1 | 0.230 |
Why?
| | Amyloidosis | 2 | 2002 | 44 | 0.230 |
Why?
| | Protein Structure, Quaternary | 4 | 2011 | 126 | 0.230 |
Why?
| | Injections, Subcutaneous | 2 | 2016 | 154 | 0.230 |
Why?
| | Bacterial Vaccines | 3 | 2009 | 63 | 0.230 |
Why?
| | Phage Therapy | 1 | 2024 | 15 | 0.230 |
Why?
| | Hydrolysis | 1 | 2025 | 191 | 0.220 |
Why?
| | Platelet Aggregation | 1 | 2005 | 100 | 0.220 |
Why?
| | Supervised Machine Learning | 1 | 2024 | 17 | 0.220 |
Why?
| | Bone Cements | 1 | 2024 | 42 | 0.220 |
Why?
| | Cattle | 6 | 2015 | 982 | 0.220 |
Why?
| | Jurkat Cells | 1 | 2024 | 134 | 0.220 |
Why?
| | Desiccation | 2 | 2021 | 20 | 0.210 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2015 | 2066 | 0.210 |
Why?
| | Ions | 2 | 2002 | 72 | 0.210 |
Why?
| | Vitreous Body | 2 | 2003 | 110 | 0.210 |
Why?
| | Fibroblast Growth Factor 10 | 2 | 2013 | 23 | 0.200 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2003 | 184 | 0.200 |
Why?
| | Disaccharides | 3 | 2013 | 19 | 0.200 |
Why?
| | Diffusion | 3 | 2016 | 120 | 0.200 |
Why?
| | Bias | 1 | 2024 | 221 | 0.200 |
Why?
| | Vaccines, DNA | 1 | 2002 | 32 | 0.200 |
Why?
| | Peroxides | 1 | 2022 | 19 | 0.190 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2019 | 134 | 0.190 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 501 | 0.190 |
Why?
| | Time Factors | 9 | 2021 | 6817 | 0.190 |
Why?
| | Fatty Acids | 1 | 2025 | 445 | 0.180 |
Why?
| | Gentamicins | 2 | 1998 | 54 | 0.180 |
Why?
| | Primates | 1 | 2022 | 125 | 0.180 |
Why?
| | Metals | 2 | 2013 | 136 | 0.180 |
Why?
| | Subtilisin | 1 | 2000 | 4 | 0.180 |
Why?
| | Coloring Agents | 2 | 2002 | 86 | 0.180 |
Why?
| | Mannitol | 3 | 2019 | 38 | 0.180 |
Why?
| | Tryptophan | 3 | 2013 | 183 | 0.180 |
Why?
| | Laboratories | 1 | 2021 | 113 | 0.170 |
Why?
| | Oxidation-Reduction | 7 | 2012 | 1059 | 0.170 |
Why?
| | Dextrans | 7 | 2000 | 84 | 0.170 |
Why?
| | Immunization | 1 | 2023 | 414 | 0.170 |
Why?
| | Isoniazid | 3 | 2006 | 64 | 0.170 |
Why?
| | Spectrophotometry, Ultraviolet | 7 | 2014 | 86 | 0.170 |
Why?
| | Solvents | 4 | 2004 | 108 | 0.170 |
Why?
| | High-Throughput Screening Assays | 1 | 2022 | 159 | 0.170 |
Why?
| | Models, Molecular | 4 | 2016 | 1586 | 0.160 |
Why?
| | Silicon Dioxide | 2 | 2015 | 116 | 0.160 |
Why?
| | Elasticity | 2 | 2018 | 195 | 0.160 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 849 | 0.160 |
Why?
| | Structure-Activity Relationship | 4 | 2011 | 586 | 0.160 |
Why?
| | Complement C4a | 1 | 2019 | 9 | 0.160 |
Why?
| | Complement C5a | 1 | 2019 | 71 | 0.160 |
Why?
| | Plasticizers | 1 | 2019 | 15 | 0.160 |
Why?
| | beta-Lactamases | 1 | 1999 | 47 | 0.160 |
Why?
| | Sensitivity and Specificity | 3 | 2018 | 1950 | 0.160 |
Why?
| | Electron Spin Resonance Spectroscopy | 7 | 2000 | 94 | 0.160 |
Why?
| | Complement C3a | 1 | 2019 | 42 | 0.160 |
Why?
| | Thromboplastin | 1 | 1999 | 74 | 0.160 |
Why?
| | Pharmaceutic Aids | 1 | 1998 | 1 | 0.150 |
Why?
| | Complement Factor B | 1 | 2019 | 109 | 0.150 |
Why?
| | Complement C3 | 1 | 2019 | 210 | 0.150 |
Why?
| | Calibration | 1 | 2018 | 146 | 0.150 |
Why?
| | Models, Theoretical | 2 | 2018 | 576 | 0.140 |
Why?
| | Poliovirus Vaccine, Inactivated | 1 | 2018 | 28 | 0.140 |
Why?
| | Microscopy, Fluorescence | 2 | 2018 | 402 | 0.140 |
Why?
| | Dosage Forms | 1 | 1997 | 12 | 0.140 |
Why?
| | Photolysis | 2 | 2018 | 91 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 2 | 2014 | 533 | 0.140 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2011 | 619 | 0.140 |
Why?
| | Biophysical Phenomena | 1 | 2017 | 65 | 0.140 |
Why?
| | Optical Imaging | 1 | 2018 | 63 | 0.140 |
Why?
| | Crystallography, X-Ray | 2 | 2009 | 474 | 0.140 |
Why?
| | Immune Tolerance | 2 | 2017 | 362 | 0.130 |
Why?
| | Viscoelastic Substances | 1 | 2016 | 10 | 0.130 |
Why?
| | Quaternary Ammonium Compounds | 3 | 2006 | 53 | 0.130 |
Why?
| | Suspensions | 1 | 2016 | 37 | 0.130 |
Why?
| | Immunoproteins | 1 | 2016 | 1 | 0.130 |
Why?
| | Mice, Transgenic | 3 | 2017 | 2182 | 0.130 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2017 | 77 | 0.130 |
Why?
| | Software | 1 | 2021 | 670 | 0.130 |
Why?
| | Anti-Bacterial Agents | 2 | 2024 | 1800 | 0.130 |
Why?
| | Sodium Dodecyl Sulfate | 2 | 2006 | 26 | 0.120 |
Why?
| | Electrochemistry | 4 | 2016 | 80 | 0.120 |
Why?
| | Neutralization Tests | 1 | 2015 | 75 | 0.120 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2014 | 180 | 0.120 |
Why?
| | Cresols | 1 | 2014 | 4 | 0.110 |
Why?
| | Erythropoietin | 1 | 2015 | 95 | 0.110 |
Why?
| | Phenol | 1 | 2014 | 20 | 0.110 |
Why?
| | Cricetinae | 2 | 2012 | 288 | 0.110 |
Why?
| | Glutathione Disulfide | 2 | 2005 | 33 | 0.110 |
Why?
| | Calorimetry | 2 | 2008 | 69 | 0.110 |
Why?
| | Micropore Filters | 1 | 2014 | 6 | 0.110 |
Why?
| | Models, Animal | 1 | 2016 | 387 | 0.110 |
Why?
| | Insulin Lispro | 1 | 2014 | 39 | 0.110 |
Why?
| | Parvovirus | 1 | 2014 | 13 | 0.110 |
Why?
| | Insulin Aspart | 1 | 2014 | 27 | 0.110 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2014 | 28 | 0.110 |
Why?
| | Biofouling | 1 | 2014 | 9 | 0.110 |
Why?
| | Cross Reactions | 1 | 2014 | 133 | 0.110 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2014 | 141 | 0.110 |
Why?
| | Immunoglobulin Light Chains | 3 | 2003 | 47 | 0.110 |
Why?
| | In Vitro Techniques | 4 | 2005 | 1108 | 0.100 |
Why?
| | Lactates | 1 | 1993 | 85 | 0.100 |
Why?
| | Ferrous Compounds | 1 | 2013 | 23 | 0.100 |
Why?
| | Silicates | 1 | 2012 | 15 | 0.100 |
Why?
| | Silicones | 1 | 2012 | 25 | 0.100 |
Why?
| | Sodium Chloride | 4 | 2013 | 143 | 0.100 |
Why?
| | Epitopes | 1 | 2015 | 481 | 0.100 |
Why?
| | Boron Compounds | 1 | 2012 | 27 | 0.100 |
Why?
| | Isoenzymes | 2 | 2001 | 305 | 0.100 |
Why?
| | Trace Elements | 1 | 2013 | 52 | 0.100 |
Why?
| | X-Ray Diffraction | 2 | 2005 | 104 | 0.100 |
Why?
| | Mice, Nude | 1 | 2014 | 696 | 0.100 |
Why?
| | Carbonic Anhydrases | 1 | 1992 | 14 | 0.100 |
Why?
| | Antitubercular Agents | 2 | 2005 | 206 | 0.100 |
Why?
| | Spectrum Analysis | 3 | 2008 | 91 | 0.090 |
Why?
| | Polystyrenes | 1 | 2011 | 36 | 0.090 |
Why?
| | Biopharmaceutics | 1 | 2011 | 2 | 0.090 |
Why?
| | Spectrophotometry | 2 | 2001 | 61 | 0.090 |
Why?
| | Phospholipids | 1 | 2013 | 223 | 0.090 |
Why?
| | Weight Gain | 2 | 2013 | 518 | 0.090 |
Why?
| | Rats | 4 | 2010 | 5676 | 0.090 |
Why?
| | Interferon-beta | 1 | 2011 | 92 | 0.090 |
Why?
| | Carbohydrates | 4 | 2013 | 67 | 0.090 |
Why?
| | Salts | 2 | 2008 | 37 | 0.090 |
Why?
| | Binding Sites | 3 | 2011 | 1310 | 0.090 |
Why?
| | Hypophysectomy | 1 | 2010 | 15 | 0.090 |
Why?
| | Fermentation | 1 | 2010 | 29 | 0.080 |
Why?
| | Chromatography, Ion Exchange | 1 | 2010 | 54 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2009 | 2146 | 0.080 |
Why?
| | beta-Cyclodextrins | 1 | 2010 | 30 | 0.080 |
Why?
| | Tungsten Compounds | 1 | 2009 | 3 | 0.080 |
Why?
| | Steel | 1 | 2009 | 6 | 0.080 |
Why?
| | Aluminum Compounds | 1 | 2009 | 6 | 0.080 |
Why?
| | Microscopy, Atomic Force | 1 | 2010 | 126 | 0.080 |
Why?
| | Phase Transition | 1 | 2009 | 24 | 0.080 |
Why?
| | Molecular Sequence Data | 3 | 2009 | 2901 | 0.080 |
Why?
| | Computer Simulation | 2 | 2025 | 986 | 0.080 |
Why?
| | Oxides | 1 | 2009 | 45 | 0.080 |
Why?
| | Bacteriophage T4 | 1 | 2009 | 15 | 0.080 |
Why?
| | Clostridium botulinum | 1 | 2008 | 4 | 0.080 |
Why?
| | Factor XIII | 2 | 1998 | 11 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 3 | 2010 | 2501 | 0.080 |
Why?
| | Powder Diffraction | 1 | 2008 | 3 | 0.070 |
Why?
| | Ultracentrifugation | 3 | 2009 | 52 | 0.070 |
Why?
| | Immunization, Secondary | 1 | 2009 | 89 | 0.070 |
Why?
| | Biodegradation, Environmental | 2 | 2002 | 86 | 0.070 |
Why?
| | Succinates | 1 | 2008 | 23 | 0.070 |
Why?
| | Protein Renaturation | 2 | 2005 | 4 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2009 | 193 | 0.070 |
Why?
| | Molecular Structure | 2 | 2006 | 508 | 0.070 |
Why?
| | Chemical Phenomena | 3 | 2014 | 85 | 0.070 |
Why?
| | Nanotechnology | 1 | 2009 | 126 | 0.070 |
Why?
| | Micelles | 2 | 2005 | 40 | 0.070 |
Why?
| | Fractionation, Field Flow | 1 | 2007 | 4 | 0.070 |
Why?
| | Molecular Conformation | 1 | 2007 | 152 | 0.070 |
Why?
| | Hydrogen | 3 | 2003 | 72 | 0.070 |
Why?
| | Immunoglobulin E | 1 | 2009 | 341 | 0.070 |
Why?
| | Actins | 2 | 2000 | 416 | 0.070 |
Why?
| | Deuterium | 3 | 2003 | 98 | 0.070 |
Why?
| | Congo Red | 2 | 2003 | 9 | 0.060 |
Why?
| | Dithiothreitol | 1 | 2005 | 17 | 0.060 |
Why?
| | Chromatography, Supercritical Fluid | 1 | 2005 | 3 | 0.060 |
Why?
| | Biometry | 1 | 2006 | 70 | 0.060 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2008 | 340 | 0.060 |
Why?
| | Poliomyelitis | 2 | 2018 | 37 | 0.060 |
Why?
| | Bacillus | 1 | 2005 | 15 | 0.060 |
Why?
| | alpha-Amylases | 1 | 2005 | 16 | 0.060 |
Why?
| | Trichoderma | 1 | 2005 | 28 | 0.060 |
Why?
| | Detergents | 1 | 2005 | 44 | 0.060 |
Why?
| | Immunoglobulin Variable Region | 2 | 2003 | 80 | 0.060 |
Why?
| | Receptors, Interleukin-1 | 3 | 2005 | 216 | 0.060 |
Why?
| | Hypoglycemic Agents | 1 | 2014 | 1285 | 0.060 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2004 | 54 | 0.060 |
Why?
| | Cell Line | 3 | 2006 | 2852 | 0.060 |
Why?
| | Data Interpretation, Statistical | 1 | 2006 | 352 | 0.060 |
Why?
| | Interleukin-11 | 1 | 2004 | 10 | 0.060 |
Why?
| | Fluorescence | 3 | 2013 | 161 | 0.060 |
Why?
| | Arginine | 1 | 2005 | 274 | 0.050 |
Why?
| | Models, Biological | 2 | 2003 | 1775 | 0.050 |
Why?
| | Nucleic Acid Conformation | 1 | 2007 | 720 | 0.050 |
Why?
| | Tacrine | 1 | 2002 | 1 | 0.050 |
Why?
| | Phenylephrine | 1 | 2002 | 76 | 0.050 |
Why?
| | Male | 5 | 2017 | 67718 | 0.050 |
Why?
| | Methods | 1 | 2002 | 65 | 0.050 |
Why?
| | Tyrosine | 1 | 2003 | 224 | 0.050 |
Why?
| | Time | 1 | 2002 | 82 | 0.050 |
Why?
| | Models, Statistical | 1 | 2006 | 667 | 0.050 |
Why?
| | Prodrugs | 1 | 2002 | 49 | 0.050 |
Why?
| | L-Selectin | 1 | 2001 | 26 | 0.050 |
Why?
| | Drug Interactions | 2 | 2004 | 409 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2001 | 121 | 0.040 |
Why?
| | Borates | 1 | 2000 | 3 | 0.040 |
Why?
| | Chemistry, Physical | 2 | 1997 | 38 | 0.040 |
Why?
| | Myoglobin | 1 | 2000 | 13 | 0.040 |
Why?
| | Drug Design | 1 | 2002 | 170 | 0.040 |
Why?
| | Nerve Growth Factor | 1 | 2000 | 30 | 0.040 |
Why?
| | Cytochrome c Group | 1 | 2000 | 43 | 0.040 |
Why?
| | Free Radical Scavengers | 1 | 2000 | 89 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2003 | 619 | 0.040 |
Why?
| | RNA | 1 | 2007 | 924 | 0.040 |
Why?
| | Electric Conductivity | 1 | 2000 | 95 | 0.040 |
Why?
| | Bence Jones Protein | 1 | 2000 | 1 | 0.040 |
Why?
| | Permeability | 1 | 2000 | 162 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 1999 | 10 | 0.040 |
Why?
| | Mitosporic Fungi | 1 | 1999 | 7 | 0.040 |
Why?
| | Calcium | 1 | 2005 | 1233 | 0.040 |
Why?
| | Refractometry | 1 | 1999 | 31 | 0.040 |
Why?
| | Bacteria | 1 | 2006 | 858 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2003 | 599 | 0.040 |
Why?
| | Hydrogels | 2 | 2021 | 675 | 0.040 |
Why?
| | Fungal Proteins | 1 | 1999 | 134 | 0.040 |
Why?
| | Macromolecular Substances | 1 | 1999 | 227 | 0.040 |
Why?
| | Centrifugation | 1 | 2018 | 30 | 0.040 |
Why?
| | Copper | 1 | 1999 | 109 | 0.040 |
Why?
| | Phosphates | 2 | 2010 | 184 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2022 | 3292 | 0.040 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 1999 | 134 | 0.040 |
Why?
| | Self Administration | 1 | 2018 | 123 | 0.040 |
Why?
| | Potassium Chloride | 1 | 1997 | 40 | 0.030 |
Why?
| | Zinc | 1 | 2000 | 298 | 0.030 |
Why?
| | Proteolysis | 1 | 2018 | 180 | 0.030 |
Why?
| | Interferons | 1 | 1998 | 199 | 0.030 |
Why?
| | Parkinson Disease | 1 | 2003 | 495 | 0.030 |
Why?
| | Povidone | 1 | 1996 | 5 | 0.030 |
Why?
| | Pregnancy | 1 | 2009 | 6745 | 0.030 |
Why?
| | Epoetin Alfa | 1 | 2015 | 9 | 0.030 |
Why?
| | Viral Proteins | 1 | 2018 | 346 | 0.030 |
Why?
| | Species Specificity | 1 | 2016 | 593 | 0.030 |
Why?
| | Isoelectric Point | 1 | 2014 | 25 | 0.030 |
Why?
| | Rabbits | 3 | 2001 | 792 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 1998 | 424 | 0.030 |
Why?
| | Hypodermoclysis | 1 | 2013 | 4 | 0.030 |
Why?
| | Horses | 3 | 2003 | 110 | 0.030 |
Why?
| | Injections, Intraperitoneal | 1 | 2013 | 115 | 0.030 |
Why?
| | Acrylamides | 1 | 2013 | 57 | 0.030 |
Why?
| | Sulfites | 1 | 2013 | 7 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2013 | 208 | 0.030 |
Why?
| | Poliovirus | 1 | 2013 | 85 | 0.030 |
Why?
| | Antigens, Viral | 1 | 2013 | 180 | 0.030 |
Why?
| | Kidney | 1 | 2001 | 1472 | 0.030 |
Why?
| | Cold Temperature | 1 | 2014 | 177 | 0.020 |
Why?
| | Lung | 1 | 2005 | 4066 | 0.020 |
Why?
| | Iodides | 1 | 1992 | 8 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2013 | 148 | 0.020 |
Why?
| | Guanidines | 1 | 1992 | 40 | 0.020 |
Why?
| | Absorption | 2 | 2004 | 61 | 0.020 |
Why?
| | Microscopy, Electron | 2 | 2003 | 434 | 0.020 |
Why?
| | Polyglycolic Acid | 1 | 2011 | 43 | 0.020 |
Why?
| | Interferon beta-1a | 1 | 2011 | 12 | 0.020 |
Why?
| | Heparin | 1 | 2013 | 259 | 0.020 |
Why?
| | Injections | 1 | 2011 | 182 | 0.020 |
Why?
| | Particulate Matter | 1 | 2013 | 314 | 0.020 |
Why?
| | 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2010 | 7 | 0.020 |
Why?
| | Clostridium | 1 | 2009 | 17 | 0.020 |
Why?
| | Equipment Design | 1 | 2011 | 526 | 0.020 |
Why?
| | Consumer Product Safety | 1 | 2009 | 34 | 0.020 |
Why?
| | Deuterium Oxide | 2 | 1999 | 16 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 664 | 0.020 |
Why?
| | Cholesterol Oxidase | 1 | 1988 | 1 | 0.020 |
Why?
| | Spores, Bacterial | 1 | 2008 | 19 | 0.020 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1988 | 8 | 0.020 |
Why?
| | Alcohol Dehydrogenase | 1 | 1988 | 16 | 0.020 |
Why?
| | Rosaniline Dyes | 1 | 2007 | 12 | 0.020 |
Why?
| | Enzymes, Immobilized | 1 | 1988 | 30 | 0.020 |
Why?
| | Peptide Mapping | 1 | 2007 | 64 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2007 | 109 | 0.020 |
Why?
| | Enzymes | 1 | 1988 | 67 | 0.020 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2005 | 10 | 0.020 |
Why?
| | Dual-Specificity Phosphatases | 1 | 2005 | 11 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2007 | 177 | 0.020 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2005 | 67 | 0.020 |
Why?
| | Prions | 1 | 2006 | 48 | 0.020 |
Why?
| | Oxidants | 1 | 2006 | 110 | 0.010 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2004 | 26 | 0.010 |
Why?
| | Ultrafiltration | 1 | 2004 | 28 | 0.010 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2005 | 171 | 0.010 |
Why?
| | Molecular Weight | 1 | 2004 | 332 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 2005 | 202 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 2005 | 228 | 0.010 |
Why?
| | Base Sequence | 1 | 2007 | 2180 | 0.010 |
Why?
| | Ribonucleases | 1 | 2003 | 55 | 0.010 |
Why?
| | Cytochromes c | 1 | 2003 | 60 | 0.010 |
Why?
| | Synucleins | 1 | 2003 | 7 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 2003 | 37 | 0.010 |
Why?
| | alpha-Synuclein | 1 | 2003 | 35 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2005 | 654 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 2003 | 212 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2003 | 309 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 123 | 0.010 |
Why?
| | Biological Transport | 1 | 2003 | 416 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2005 | 770 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2003 | 403 | 0.010 |
Why?
| | Sorbitol | 1 | 2001 | 14 | 0.010 |
Why?
| | Betaine | 1 | 2001 | 74 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2002 | 683 | 0.010 |
Why?
| | Chromatography | 1 | 2000 | 24 | 0.010 |
Why?
| | Protein Subunits | 1 | 2001 | 238 | 0.010 |
Why?
| | Muscles | 1 | 2001 | 325 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 816 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2000 | 387 | 0.010 |
Why?
| | Hydrogen Bonding | 1 | 1999 | 168 | 0.010 |
Why?
| | Swine | 1 | 2001 | 775 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2001 | 493 | 0.010 |
Why?
| | Drug Carriers | 1 | 1998 | 129 | 0.010 |
Why?
| | Lactose | 1 | 1996 | 7 | 0.010 |
Why?
| | Osteomyelitis | 1 | 1998 | 137 | 0.010 |
Why?
| | Cysteine | 1 | 1997 | 206 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2003 | 1307 | 0.010 |
Why?
| | Fructose | 1 | 1996 | 109 | 0.010 |
Why?
| | Myocardium | 1 | 2001 | 1004 | 0.010 |
Why?
| | Cyclic N-Oxides | 1 | 1995 | 29 | 0.010 |
Why?
| | Spin Labels | 1 | 1995 | 48 | 0.010 |
Why?
| | Middle Aged | 1 | 1996 | 33355 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2000 | 6059 | 0.000 |
Why?
| | Liver | 1 | 1988 | 1940 | 0.000 |
Why?
|
|
Randolph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|